Internal Medicine, Hematology & Oncology · Baton Rouge, LA
NPI
1649291667
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4950 Essen Ln, Suite 500
Baton Rouge, LA, 70809
Phone (225) 767-1311
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,277 services
Medicare patients, 2024
256
Average age 73
Drug cost, 2024
$1.2M
2,412 prescriptions
Company payments, 2025
$112
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Derrick W Spell was code 99214 (office e&m - established), 382 times for 206 patients. In total Derrick W Spell billed 1,277 services in 17 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 382 | 206 | $84.80 | $32K |
| 99215 Office E&M - Established | Office | 325 | 48 | $126.16 | $41K |
| 99205 Office E&M - New | Office | 18 | 18 | $147.69 | $2,658 |
By year: 2022 $111K for 3,050 services; 2023 $75K for 1,233 services; 2024 $81K for 1,277 services.
Medicare prescription drug claims, 2024
In 2024, the drug Derrick W Spell prescribed most often to Medicare patients was Tamoxifen Citrate, with 847 prescriptions and refills. In total Derrick W Spell wrote 2,412 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamoxifen Citrate Generic | 847 | 1,639 | 173 | $18K |
| Anastrozole Generic | 551 | 1,062 | 118 | $8,380 |
| Gabapentin Generic | 139 | 185 | 29 | $1,590 |
| Letrozole Generic | 131 | 208 | 31 | $2,070 |
| Citalopram Hbr Citalopram Hydrobromide | 101 | 184 | 23 | $285 |
| Verzenio Abemaciclib | 67 | 67 | 15 | $971K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 57 | 57 | 12 | $1,406 |
| Ondansetron Hcl Generic | 54 | 54 | 16 | $278 |
| Xarelto Rivaroxaban | 43 | 55 | Under 11 | $30K |
| Exemestane Generic | 42 | 68 | 12 | $3,602 |
| Alendronate Sodium Generic | 40 | 53 | Under 11 | $129 |
| Escitalopram Oxalate Generic | 29 | 61 | Under 11 | $277 |
| Oxycodone Hcl Generic | 28 | 28 | Under 11 | $1,176 |
| Alprazolam Generic | 23 | 23 | Under 11 | $58.63 |
| Eliquis Apixaban | 21 | 25 | Under 11 | $11K |
Brand drugs: 157 claims; generic drugs: 2,255 claims; opioid claims: 100.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Derrick W Spell $112 ($112 in general payments such as food, travel and fees) from 4 companies. The largest payer was Pfizer Inc. with $56.21.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.